The active ingredient in this medicine is adalimumab, which is a fully human monoclonal antibody. Monoclonal antibodies are proteins made by a type of blood cell to fight a foreign protein in the body. Adalimumab recognizes and binds to a specific protein (tumour necrosis factor or TNF-alpha), which is present at higher levels in some inflammatory diseases.
Humira is used for the treatment of a number of inflammatory diseases:
Polyarticular Juvenile Idiopathic Arthritis (pJIA)
Enthesitis-related arthritis (ERA)
Psoriatic arthritis (PsA)
Hidradenitis suppurativa (HS)
This is the last line in the description